
Orion Properties Inc.
ONLNYSECIK 1873923Real estateFiscal year ends Dec 31
Reports and events: 68 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0616:34 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001873923-26-000107 |
| 2026-08-0616:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-26-000105 |
| 2026-05-1316:42 ET | 8-K | 5.07 Shareholder vote results | 0001873923-26-000085 |
| 2026-05-0716:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001873923-26-000082 |
| 2026-05-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-26-000081 |
| 2026-03-2016:05 ET | DEF 14A | Proxy statementPeriod 2026-05-13 | 0001873923-26-000073 |
| 2026-03-0516:18 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001873923-26-000038 |
| 2026-03-0516:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-26-000037 |
| 2026-02-1908:03 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001873923-26-000023 |
| 2026-01-2615:24 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001534242-26-000002 |
| 2026-01-2607:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001873923-26-000017 |
| 2025-11-1818:18 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001534242-25-000016 |
| 2025-11-1016:49 ET | 8-K | 1.02 Termination of a material agreement | 0001873923-25-000141 |
| 2025-11-0616:24 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001873923-25-000130 |
| 2025-11-0616:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-25-000129 |
| 2025-09-2216:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001873923-25-000124 |
| 2025-08-0616:21 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001873923-25-000117 |
| 2025-08-0616:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-25-000116 |
| 2025-07-1712:50 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001534242-25-000013 |
| 2025-06-2015:16 ET | SCHEDULE 13D | Ownership report, active investor | 0001534242-25-000010 |
| 2025-05-1416:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001873923-25-000085 |
| 2025-05-0716:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001873923-25-000082 |
| 2025-05-0716:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-25-000081 |
| 2025-04-1107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001873923-25-000076 |
| 2025-03-2116:38 ET | DEF 14A | Proxy statementPeriod 2025-05-14 | 0001873923-25-000058 |
| 2025-03-0716:02 ET | 8-K | 8.01 Other events | 0001873923-25-000034 |
| 2025-03-0516:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001873923-25-000032 |
| 2025-03-0516:19 ET | 8-K | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001873923-25-000031 |
| 2024-11-2716:11 ET | 8-K | 8.01 Other events | 0001873923-24-000113 |
| 2024-11-2216:05 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-24-000106 |
| 2024-11-0716:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001873923-24-000095 |
| 2024-11-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-24-000094 |
| 2024-08-0816:22 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001873923-24-000084 |
| 2024-08-0816:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-24-000083 |
| 2024-05-1516:18 ET | 8-K | 5.07 Shareholder vote results | 0001873923-24-000065 |
| 2024-05-0816:24 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001873923-24-000061 |
| 2024-05-0816:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-24-000060 |
| 2024-03-2216:20 ET | DEF 14A | Proxy statementPeriod 2024-05-15 | 0001873923-24-000041 |
| 2024-02-2716:25 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001873923-24-000008 |
| 2024-02-2716:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-24-000007 |
| 2023-11-0916:21 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001873923-23-000096 |
| 2023-11-0916:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-23-000095 |
| 2023-09-0817:22 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001873923-23-000086 |
| 2023-08-0916:19 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001873923-23-000078 |
| 2023-08-0916:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-23-000077 |
| 2023-06-2916:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-178599 |
| 2023-05-1816:14 ET | 8-K | 5.07 Shareholder vote results | 0001873923-23-000053 |
| 2023-05-0916:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001873923-23-000048 |
| 2023-05-0916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001873923-23-000047 |
| 2023-03-2417:14 ET | DEF 14A | Proxy statementPeriod 2023-05-16 | 0001873923-23-000026 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.